Collagen on a GLP-1: What the Evidence Supports

Of the supplements people ask about on a GLP-1, collagen usually arrives attached to one specific worry: loose skin. The marketing is confident, the aisle is crowded, and the research file is genuinely mixed in a way that single headlines do not carry. Two reviews published within a year of each other show the problem exactly, because they look at much the same body of trials and leave a different impression of it. Working out why they differ is more useful than picking one to believe, and the skill transfers to every supplement question that follows this one.

The review that filtered for funding and quality

The first is a systematic review and meta-analysis of randomized controlled trials, published in The American Journal of Medicine in 2025. It pooled 23 trials and 1,474 participants, and on the pooled numbers collagen supplements significantly improved skin hydration, elasticity and wrinkles. That is the headline version, and it is a fair summary of the pooling as it stands.

The same paper then takes the pooling apart, and that is where it becomes the more useful of the two for a reader. Split by funding source, trials not funded by pharmaceutical companies showed no effect on hydration, elasticity or wrinkles, while trials that were funded by them did show significant effects. Split by study quality, high-quality studies showed no significant effect in any category, and only the low-quality studies showed a significant improvement, in elasticity. The authors' stated conclusion follows from those splits: there is currently no clinical evidence to support the use of collagen supplements to prevent or treat skin aging.

The umbrella review that found consistent benefits

The second is an umbrella review, published in Aesthetic Surgery Journal Open Forum in 2026, with a search of the literature through March 2025. Where a meta-analysis pools trials, an umbrella review pools systematic reviews: this one covered 16 of them, together accounting for 113 randomized trials and 7,983 patients. It reports that collagen supplementation was consistently associated with favorable outcomes for skin, musculoskeletal health and osteoarthritis, with mixed results for oral health and cardiometabolic measures, and it concludes that collagen supplementation demonstrates consistent and clinically meaningful benefits for dermal, bone and muscular health. The paper grades its own level of evidence as 3, therapeutic.

Why two reviews disagree

The disagreement is structural rather than a case of one paper simply being wrong. An umbrella review summarizes what the existing reviews found, and it inherits their methods: if the reviews underneath pooled trials without filtering for funding source or methodology, the umbrella carries that unfiltered pooling upward. The American Journal of Medicine review asked a narrower question, whether the pooled effect survives a filter for funding and study quality, and found that it does not. Both papers are describing the same trials, and both are internally honest about what they did.

A reader who meets only the headline from either one walks away with a different impression of the same literature. Recognizing that pattern is the transferable lesson, and it is the same discipline we ask for when reading any confident claim about a medication: what was pooled, what was filtered for, and who paid. The habit has a home page of its own at How to Read Your GLP-1's Prescribing Information.

GLP 1 Tracker AppProtein, water, weight and doses in one private place, so a limited appetite is managed from data rather than guesswork. Free, no account, nothing leaves your phone. Get the app

What neither review covers

The limits that matter most here are population limits. Neither review addresses skin laxity after major weight loss; the trials behind them measured skin aging, hydration, elasticity and wrinkles in people who were not losing substantial weight. Neither includes anyone taking a GLP-1 medication. And no GLP-1 label mentions collagen at all. Carrying this evidence across to loose skin on a GLP-1, in either direction, is an extrapolation with nothing underneath it.

On the practical question of loose skin after weight loss, we recommend no creams, collagen supplements, devices or procedures of any kind, and we make no claim that anything tightens skin. The fuller picture is at Loose Skin and Rapid Weight Loss.

Collagen as a protein, and the caveats that come with it

One nutrition point is worth keeping, short and uncontroversial. Collagen is a protein, but it is low in some essential amino acids, and nutrition guidance does not treat collagen peptides as interchangeable with complete protein sources such as dairy, eggs, fish or meat. For someone on a GLP-1 chasing a daily protein target with a limited appetite, that distinction is the practically relevant one: a serving of collagen does not stand in for the complete protein it might crowd out of a small day of eating. The target itself, and how people reach it on a suppressed appetite, is the subject of Protein Goals on GLP-1s: Protecting Muscle While Losing Weight.

The supplement caveats are the standard ones, laid out in the register of Supplements on a GLP-1: What to Ask Your Clinician About. Supplements are regulated differently from medicines, so content and purity vary by product, and anything taken alongside a prescription is a conversation with a clinician or pharmacist. That conversation is where brands, products and doses can be weighed for a specific person, alongside their medication list and their lab schedule.